Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)
Conditions: Japanese Encephalitis; Measles; Mumps; Rubella Interventions: Biological: Vero cell-drived inactive Japanese encephalitis vaccine; Biological: Measles-Mumps-Rubella Vaccine Sponsors: Liaoning Chengda Biotechnology CO., LTD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants
Conditions: Salmonella Infections Interventions: Biological: Measles and Rubella vaccine; Biological: Yellow Fever vaccine; Biological: Pentavalent vaccine; Biological: Pneumococcal vaccine; Biological: Inactivated polio vaccine; Biological: iNTS-GMMA Dose C; Biological: iNTS-GMMA Dose B; Biological: iNTS-GMMA Dose A; Biological: MenACWY; Combination Product: DTPa-HBV-IPV+Hib; Drug: Placebo Sponsors: GlaxoSmithKline; European& Developing Countries Clinical Trials Partnership; Kwame Nkrumah University of Science and Technology; Pedvac iNTS consortium Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines
Conditions: SARS-CoV-2 Infection; Varicella; Measles; Mumps; Rubella Interventions: Biological: Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine; Biological: Inactivated SARS-CoV-2 vaccine coadministered with MMR; Biological: Inactivated SARS-CoV-2 vaccine administered alone Sponsors: Shanghai Municipal Center for Disease Control and Prevention; China National Biotec Group Company Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2023 Category: Research Source Type: clinical trials
